Literature DB >> 24078061

Pyrithiamine-induced thiamine deficiency alters proliferation and neurogenesis in both neurogenic and vulnerable areas of the rat brain.

Alan S Hazell, Dongmei Wang, Raluca Oanea, Simon Sun, Meghmik Aghourian, Jee Jung Yong.   

Abstract

Thiamine deficiency (TD) leads to Wernicke's encephalopathy (WE), in which focal histological lesions occur in periventricular areas of the brain. Recently, impaired neurogenesis has been reported in the hippocampus during the dietary form of TD, and in pyrithiamine-induced TD (PTD), a well-characterized model of WE. To further characterize the consequences of PTD on neural stem/progenitor cell (NSPC) activity, we have examined the effect of this treatment in the rat on both the subventricular zone (SVZ) of the rostral lateral ventricle and subgranular layer (SGL) of the hippocampus, and in the thalamus and inferior colliculus, two vulnerable brain regions in this disorder. In both the SVZ and SGL, PTD led to a decrease in the numbers of bromodeoxyuridine-stained cells, indicating that proliferation of NSPCs destined for neurogenesis in these areas was reduced. Doublecortin (DCX) immunostaining in the SGL was decreased, indicating a reduction in neuroblast formation, consistent with impaired NSPC activity. DCX labeling was not apparent in focal areas of vulnerability. In the thalamus, proliferation of cells was absent while in the inferior colliculus, numerous actively dividing cells were apparent, indicative of a differential response between these two brain regions. Exposure of cultured neurospheres to PTD resulted in decreased proliferation of NSPCs, consistent with our in vivo findings. Together, these results indicate that PTD considerably affects cell proliferation and neurogenesis activity in both neurogenic areas and parts of the brain known to display structural and functional vulnerability, confirming and extending recent findings on the effects of TD on neurogenesis. Future use of NSPCs in vitro may allow a closer and more detailed examination of the mechanism(s) underlying inhibition of these cells during TD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24078061     DOI: 10.1007/s11011-013-9436-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  43 in total

1.  Decreased metabolism in vivo of glucose into amino acids of the brain of thiamine-deficient rats after treatment with pyrithiamine.

Authors:  M K Gaitonde; N A Fayein; A L Johnson
Journal:  J Neurochem       Date:  1975-06       Impact factor: 5.372

Review 2.  Neurogenesis and brain injury: managing a renewable resource for repair.

Authors:  Anna F Hallbergson; Carmen Gnatenco; Daniel A Peterson
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

3.  Preconditioning-induced ischemic tolerance stimulates growth factor expression and neurogenesis in adult rat hippocampus.

Authors:  Michelle Naylor; Kellie K Bowen; Kurt A Sailor; Robert J Dempsey; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2005-09-09       Impact factor: 3.921

4.  Enhancement of progenitor cell division in the dentate gyrus triggered by initial limbic seizures in rat models of epilepsy.

Authors:  E Nakagawa; Y Aimi; O Yasuhara; I Tooyama; M Shimada; P L McGeer; H Kimura
Journal:  Epilepsia       Date:  2000-01       Impact factor: 5.864

5.  Differentiation between brain lesions in experimental thiamine deficiency.

Authors:  A O Vortmeyer; H J Colmant
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 6.  Isolation, characterization, and use of stem cells from the CNS.

Authors:  F H Gage; J Ray; L J Fisher
Journal:  Annu Rev Neurosci       Date:  1995       Impact factor: 12.449

7.  The incidence of Wernicke's encephalopathy in Australia--a neuropathological study of 131 cases.

Authors:  C Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

8.  The production of macrophage inflammatory protein-2 induced by soluble intercellular adhesion molecule-1 in mouse astrocytes is mediated by src tyrosine kinases and p42/44 mitogen-activated protein kinase.

Authors:  Vivianne I Otto; Sergio M Gloor; Stefan Frentzel; Urs Gilli; Emerita Ammann; Andreas E Hein; Gerd Folkers; Otmar Trentz; Thomas Kossmann; Maria C Morganti-Kossmann
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

9.  Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes.

Authors:  Alan S Hazell; Pierre Pannunzio; K V Rama Rao; David V Pow; Andrea Rambaldi
Journal:  Glia       Date:  2003-08       Impact factor: 7.452

10.  Impaired hippocampal neurogenesis is involved in cognitive dysfunction induced by thiamine deficiency at early pre-pathological lesion stage.

Authors:  Na Zhao; Chunjiu Zhong; Yang Wang; Yanling Zhao; Neng Gong; Guomin Zhou; Tianle Xu; Zhen Hong
Journal:  Neurobiol Dis       Date:  2007-09-07       Impact factor: 5.996

View more
  4 in total

1.  Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.

Authors:  Prapaporn Jungtrakoon; Jun Shirakawa; Patinut Buranasupkajorn; Manoj K Gupta; Dario F De Jesus; Marcus G Pezzolesi; Aussara Panya; Timothy Hastings; Chutima Chanprasert; Christine Mendonca; Rohit N Kulkarni; Alessandro Doria
Journal:  Diabetes       Date:  2019-03-04       Impact factor: 9.461

Review 2.  Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Authors:  Eman Abdou; Alan S Hazell
Journal:  Neurochem Res       Date:  2014-10-09       Impact factor: 3.996

Review 3.  Thiamine and selected thiamine antivitamins - biological activity and methods of synthesis.

Authors:  Adam Tylicki; Zenon Łotowski; Magdalena Siemieniuk; Artur Ratkiewicz
Journal:  Biosci Rep       Date:  2018-01-10       Impact factor: 3.840

4.  Thiamine and benfotiamine protect neuroblastoma cells against paraquat and β-amyloid toxicity by a coenzyme-independent mechanism.

Authors:  Margaux Sambon; Aurore Napp; Alice Demelenne; Julie Vignisse; Pierre Wins; Marianne Fillet; Lucien Bettendorff
Journal:  Heliyon       Date:  2019-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.